Glibenclamide Administration Attenuates Infarct Volume, Hemispheric Swelling, and Functional Impairments following Permanent Focal Cerebral Ischemia in Rats

<table>Glib improves neurological functions in a rat model of pMCAO. Treatments with Glib significantly decreased the NSS compared to the vehicle-treated group at 48 h after occlusion. <i>P</i> &lt; 0.05; *significant difference compared to MCAO + Vehicle. Values are expressed as mean ± SE.</table>

Stroke Research and Treatment

fig3

Figure 3

Figure 3: Glibenclamide Administration Attenuates Infarct Volume, Hemispheric Swelling, and Functional Impairments following Permanent Focal Cerebral Ischemia in Rats 

Figure 3 | Glibenclamide Administration Attenuates Infarct Volume, Hemispheric Swelling, and Functional Impairments following Permanent Focal Cerebral Ischemia in Rats 